| 000 | 01553 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515015711.0 | ||
| 264 | 0 | _c20060321 | |
| 008 | 200603s 0 0 eng d | ||
| 022 | _a0753-3322 | ||
| 024 | 7 |
_a10.1016/s0753-3322(05)80043-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChan, C M L | |
| 245 | 0 | 0 |
_aCelecoxib induces dose dependent growth inhibition in nasopharyngeal carcinoma cell lines independent of cyclooxygenase-2 expression. _h[electronic resource] |
| 260 |
_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cOct 2005 |
||
| 300 |
_aS268-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCelecoxib |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCyclin D1 _xbiosynthesis |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xbiosynthesis |
| 650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNasopharyngeal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 | _aTetrazolium Salts |
| 650 | 0 | 4 | _aThiazoles |
| 700 | 1 | _aMa, B B Y | |
| 700 | 1 | _aWong, S C | |
| 700 | 1 | _aChan, A T C | |
| 773 | 0 |
_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 59 Suppl 2 _gp. S268-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0753-3322(05)80043-5 _zAvailable from publisher's website |
| 999 |
_c16117868 _d16117868 |
||